These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1539260)

  • 21. The role of cyclosporine-induced autoreactive T lymphocytes in solid organ allograft survival and chronic rejection.
    Zhang H; Horwitz L; Ruvolo P; Colombani P; Hess AD
    Transplantation; 1995 Jul; 60(2):115-22. PubMed ID: 7624952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
    Mohacsi PJ; Joshi A; Wang J; Morris RE; Billingham ME
    Transplant Proc; 1994 Dec; 26(6):3255-9. PubMed ID: 7998133
    [No Abstract]   [Full Text] [Related]  

  • 23. Prolonged heart allograft survival following postoperative blood transfusion.
    Marushack MM; Snider GR; Muka-Ives M; Nelson EW; Maxwell JG; Shelby J
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1420-1. PubMed ID: 3274343
    [No Abstract]   [Full Text] [Related]  

  • 24. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
    Candinas D; Bach FH; Hancock WW
    Transplant Proc; 1996 Apr; 28(2):678. PubMed ID: 8623340
    [No Abstract]   [Full Text] [Related]  

  • 25. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: analysis of the immune status.
    Yamaguchi Y; Mori K; Bollinger RR
    J Clin Lab Immunol; 1990 Jun; 32(2):59-66. PubMed ID: 1967040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FK778, a novel immunosuppressive agent, reduces early adhesion molecule up-regulation and prolongs cardiac allograft survival.
    Schrepfer S; Deuse T; Schäfer H; Reichenspurner H
    Transpl Int; 2005 Feb; 18(2):215-20. PubMed ID: 15691275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival.
    Hölschermann H; Stadlbauer TH; Wagner AH; Fingerhuth H; Muth H; Rong S; Güler F; Tillmanns H; Hecker M
    Cardiovasc Res; 2006 Aug; 71(3):527-36. PubMed ID: 16822491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
    Nozaki S; Ito T; Kamiike W; Uchikoshi F; Ito A; Kuhara A; Nakata S; Shirakura R; Miyata M; Matsuda H
    Transplant Proc; 1995 Feb; 27(1):451-2. PubMed ID: 7879059
    [No Abstract]   [Full Text] [Related]  

  • 29. Decamer peptide derived from the alpha 1 helix of the first domain of HLA-B7 01 prolongs allograft survival in rats with an inhibition of graft infiltrating cell cytotoxicity.
    Cuturi MC; Josien R; Cantarovich D; Douillard P; Pannetier C; Smit H; Ménoret S; Pouletty P; Clayberger C; Soulillou JP
    Transplant Proc; 1995 Feb; 27(1):404-5. PubMed ID: 7879039
    [No Abstract]   [Full Text] [Related]  

  • 30. Blocking of mononuclear cell accumulation, cytokine production, and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy.
    Hancock WW; Sayegh MH; Sablinski T; Kut JP; Kupiec-Weglinski JW; Milford EL
    Transplantation; 1992 Jun; 53(6):1276-80. PubMed ID: 1604485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of action of anti-IL-2R monoclonal antibodies. ART-18 prolongs cardiac allograft survival in rats by elimination of IL-2R+ mononuclear cells.
    Tanaka K; Hancock WW; Osawa H; Stunkel KG; Alberghini TV; Diamantstein T; Tilney NL; Kupiec-Weglinski JW
    J Immunol; 1989 Nov; 143(9):2873-9. PubMed ID: 2530281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506.
    D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
    Transplant Proc; 1996 Apr; 28(2):950-1. PubMed ID: 8623476
    [No Abstract]   [Full Text] [Related]  

  • 33. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
    Rabinovitch M; Molossi S; Clausell N
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
    [No Abstract]   [Full Text] [Related]  

  • 34. Interleukin-12p70 prolongs allograft survival by induction of interferon gamma and nitric oxide production.
    Verma ND; Boyd R; Robinson C; Plain KM; Tran GT; Hall BM
    Transplantation; 2006 Nov; 82(10):1324-33. PubMed ID: 17130782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retinoic acid inhibits expression of E-selectin in endothelial cells and prolongs discordant xenograft survival.
    Blakely ML; Van der Werf WJ; Stuhlmeier K; Dalmasso AP; Winkler H; Bach FH
    Transplant Proc; 1994 Jun; 26(3):1176. PubMed ID: 7518108
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
    Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
    J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance to cardiac allografts requires a time lag between intrathymic treatment and transplantation.
    Goldstein C; Reiss GR; Mohiuddin M; Shen Z; Yokoyama H; DiSesa VJ
    J Surg Res; 1996 Jun; 63(1):83-5. PubMed ID: 8661177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unresponsiveness to rat cardiac allografts induced by intrathymic injection of donor bone marrow cells and short course of immunosuppression.
    Hara Y; Matsuura T; Imanishi M; Tahara H; Kurita T
    Transplant Proc; 1994 Dec; 26(6):3226-8. PubMed ID: 7527955
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunomodulatory effects of poly(ADP-ribose) polymerase inhibition contribute to improved cardiac function and survival during acute cardiac rejection.
    Szabó G; Bährle S; Sivanandam V; Stumpf N; Gerö D; Berger I; Beller C; Hagl S; Szabó C; Dengler TJ
    J Heart Lung Transplant; 2006 Jul; 25(7):794-804. PubMed ID: 16818122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elimination of OX8+ cells prolongs cardiac but not pancreatic allograft survival across minor (non-MHC) histocompatibility barriers.
    Roza AM; Johnson CP; Adams MB; Naji A
    Transplant Proc; 1990 Apr; 22(2):747-8. PubMed ID: 2327028
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.